omeprazole has been researched along with hydroxyurea in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Falknäs, AK; Fryklund, J; Helander, HF | 1 |
| Evans, HJ | 1 |
| Holt, S; Powers, RE; Zhu, ZH | 1 |
| Fryklund, J; Helander, HF; Larsson, H; Wallmark, B | 1 |
| Alison, MR; Bloom, SR; Ghatei, MA; Goodlad, RA; Lee, CY; Sarraf, CE; Wright, NA | 1 |
| Iwahi, T; Nagata, K; Satoh, H; Shimoyama, T; Tamura, T | 1 |
1 review(s) available for omeprazole and hydroxyurea
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for omeprazole and hydroxyurea
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Omeprazole does not cause unscheduled DNA synthesis in rabbit parietal cells in vitro.
Topics: Animals; Autoradiography; DNA; Glucose; Histamine; Hydroxyurea; In Vitro Techniques; Male; Methylnitronitrosoguanidine; Omeprazole; Oxidation-Reduction; Parietal Cells, Gastric; Rabbits; Ranitidine; Thymidine; Ultraviolet Rays | 1992 |
Genotoxicity and cell proliferation activity of omeprazole in rat stomach mucosa.
Topics: Animals; Cell Division; DNA; DNA Repair; Gastric Mucosa; Hydroxyurea; Omeprazole; Rats | 1991 |
Observations on a proposed measure of genotoxicity in rat gastric mucosa.
Topics: Animals; DNA; DNA Repair; Flow Cytometry; Gastric Mucosa; Hydroxyurea; Male; Methylnitronitrosoguanidine; Mutagenicity Tests; Omeprazole; Rats; Rats, Inbred Strains; Reproducibility of Results | 1991 |
Partial pronase digestion of rat gastric mucosa isolates cells undergoing replicative DNA synthesis.
Topics: Administration, Oral; Animals; Autoradiography; Cell Separation; DNA Replication; Fasting; Gastric Mucosa; Hydroxyurea; Male; Methylnitronitrosoguanidine; Mutagenicity Tests; Omeprazole; Pronase; Ranitidine; Rats; Rats, Inbred Strains; S Phase | 1991 |
Evaluation of a proposed technique to assess unscheduled DNA synthesis and genotoxicity.
Topics: Animals; DNA; Hydroxyurea; Methylnitronitrosoguanidine; Omeprazole; Peptide Hydrolases; Rats; Stomach | 1993 |
Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Ethylmaleimide; Helicobacter pylori; Hydroxamic Acids; Hydroxyurea; Indicators and Reagents; Iodoacetamide; Lansoprazole; Omeprazole; Oxidoreductases; Stomach; Sulfhydryl Reagents; Thiourea; Urease | 1993 |